These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21128520)

  • 1. The impact of molecular diagnostics on treatment pathways, outcomes, and cost. Introduction.
    Fine MJ
    Manag Care; 2010 Oct; 19(10 Suppl 4):1 p preceding table of contents. PubMed ID: 21128520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating in vivo diagnostics into clinical reality.
    Frangioni JV
    Nat Biotechnol; 2006 Aug; 24(8):909-13. PubMed ID: 16900127
    [No Abstract]   [Full Text] [Related]  

  • 4. Abbott Laboratories and Celera Diagnostics form alliance.
    Expert Rev Mol Diagn; 2002 Jul; 2(4):295. PubMed ID: 12138485
    [No Abstract]   [Full Text] [Related]  

  • 5. New-wave diagnostics.
    Baker M
    Nat Biotechnol; 2006 Aug; 24(8):931-8. PubMed ID: 16900134
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostics investors think positive.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):884. PubMed ID: 16900117
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of molecular diagnostics on health outcomes and cost in quality-of-care initiatives.
    Bruins C
    Manag Care; 2010 Oct; 19(10 Suppl 4):12-5. PubMed ID: 21132895
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspects of molecular diagnostics and therapy in obstetrics and gynecology.
    Beckmann MW; Strick R; Strissel PL; Fasching PA; Oppelt P; Pöhls UD; Malur SU; Ackermann S
    Expert Rev Mol Diagn; 2003 May; 3(3):279-87. PubMed ID: 12779004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and molecular diagnostics in the clinical laboratory science curriculum.
    Miller LE; Abbate S
    Clin Lab Sci; 2002; 15(3):160-6. PubMed ID: 12778962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimize the lab's test menu: how molecular dx can impact the bottom line.
    Panzer I
    MLO Med Lab Obs; 2010 Aug; 42(8):36. PubMed ID: 20734900
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building the bridge between molecular diagnostics and therapeutics.
    Schweikhardt RG; Piepenbrock C; Sledziewski AZ
    Expert Rev Mol Diagn; 2003 Nov; 3(6):681-3. PubMed ID: 14628897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human viral pathogens: conventional versus molecular approaches.
    Wu MT; Garner OB
    MLO Med Lab Obs; 2014 Jul; 46(7):8, 10-2; quiz 14. PubMed ID: 25158395
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic tests for infectious diseases in the developing world: two sides of the coin.
    Pang T; Peeling RW
    Trans R Soc Trop Med Hyg; 2007 Sep; 101(9):856-7. PubMed ID: 17544047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future of molecular diagnostics and cancer.
    Blum RA
    MLO Med Lab Obs; 2008 Mar; 40(3):30-1, 42. PubMed ID: 18429549
    [No Abstract]   [Full Text] [Related]  

  • 17. Point-of-care diagnostics: will the hurdles be overcome this time?
    Huckle D
    Expert Rev Med Devices; 2006 Jul; 3(4):421-6. PubMed ID: 16866639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic testing presents $5 billion conundrum.
    Rizk E
    Manag Care; 2009 Apr; 18(4):22, 24-5. PubMed ID: 19472563
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of continuing education interventions on clinical outcomes of patients with neck pain who received physical therapy.
    Brennan GP; Fritz JM; Hunter SJ
    Phys Ther; 2006 Sep; 86(9):1251-62. PubMed ID: 16959673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating genomic testing into oncology treatment pathways.
    Wong W
    Manag Care; 2010 Oct; 19(10 Suppl 4):16-9. PubMed ID: 21128522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.